Calluna Pharma
PrivateLast Round
Series A
Jan 23, 2024
Total Funding Raised
$81.3M
Company Overview
Calluna Pharma operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Series A round in January 2024.
Calluna Pharma is a clinical-stage biotechnology company developing a pipeline of selective antibodies to treat inflammatory and fibrotic diseases by targeting the innate immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calluna Pharma Comparables
Compare Calluna Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mediar Therapeutics | 80% | |
| Endeavor BioMedicines | 74% | |
| Ikaika Therapeutics | 68% |
For institutional investors. Book with your work email.
Calluna Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Calluna Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Investinor | Series A |
| P53 Invest | Series A |
| Sarsia | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 90% MoM.
- Dec 16, 2025
Gijs van den Brink appointed as independent director.
For institutional investors. Book with your work email.
Calluna Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Calluna Pharma's valuation, stock price, and market status.
Is Calluna Pharma a public or private company?
Calluna Pharma is a private company.
What is the current stock price of Calluna Pharma?
Calluna Pharma is a private company, so its shares have no public market price. Caplight tracks Calluna Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Calluna Pharma worth (valuation)?
Valuation information for Calluna Pharma is not publicly available.
Can I buy Calluna Pharma stock?
Calluna Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Calluna Pharma's last funding round?
Calluna Pharma's most recent funding round was Series A on January 23, 2024.
Who are the main investors in Calluna Pharma?
Key investors in Calluna Pharma include Forbion.
Will Calluna Pharma IPO soon?
No public IPO plans have been announced for Calluna Pharma.
How can I track Calluna Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Calluna Pharma's shares on secondary markets.